Literature DB >> 24046303

Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.

Sarah Tschudin-Sutter1, Pranita D Tamma, April N Naegeli, Kathleen A Speck, Aaron M Milstone, Trish M Perl.   

Abstract

BACKGROUND: Children are increasingly recognized as being at risk for C. difficile infection (CDI), even without prior exposure to antibiotics or the healthcare environment. We aimed to distinguish risk factors, clinical course, and outcomes between healthcare facility-associated (HA) and community-associated (CA) CDI.
METHODS: This was a retrospective, observational cohort study conducted at the Johns Hopkins Children's Center, Baltimore, Maryland. All inpatients, aged ≥1 year, hospitalized from July 2003 to July 2012 and diagnosed with CDI based on clinical characteristics and confirmatory laboratory testing were included. The main outcome was CDI, categorized as HA-CDI, CA-CDI, and "indeterminate" (classified as disease onset in the community, 4-12 weeks from hospital discharge).
RESULTS: Two hundred two pediatric inpatients were diagnosed with CDI, of whom 38 had CA-CDI, 144 had HA-CDI, and 20 had indeterminate CDI. Children with indeterminate CDI had baseline characteristics similar to those identified for HA-CDI. Children hospitalized with CA-CDI were less likely to have comorbidities (odds ratio [OR], 0.14; 95% confidence interval [CI], .03-.65; P = .013), to have been exposed to antibiotics (OR, 0.17; 95% CI, .07-.44; P < .001), or prior surgeries (OR, 0.03; 95% CI, .00-.24; P = .001), compared to children with HA-CDI. Compared with HA-CDI, children with CA-CDI had a trend toward more episodes of septic shock (P = .07), toxic megacolon (P = .04), and recurrences (P = .04).
CONCLUSIONS: In a hospitalized cohort, CA-CDI is more often seen in previously healthy children without antibiotic exposure or comorbid conditions and has more frequent complications and recurrences compared to HA-CDI. For surveillance purposes, "indeterminate" CDI should be allocated to HA-CDI rather than CA-CDI.

Entities:  

Keywords:  CDI; children; community-associated C. difficile infection; hospital-associated C. difficile infection; recurrence

Mesh:

Year:  2013        PMID: 24046303     DOI: 10.1093/cid/cit581

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.

Authors:  Jonathan D Crews; Hoonmo L Koo; Zhi-Dong Jiang; Jeffrey R Starke; Herbert L DuPont
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors:  Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  Community-acquired Clostridium difficile infection in Serbian pediatric population.

Authors:  Stojanović Predrag; Kocić Branislava; Stojanović Nikola; Radulovic Niko; Stojanović-Radić Zorica; Dobrila Stanković-Đorđević
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-01       Impact factor: 3.267

Review 4.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

5.  Comparative nutritional and chemical phenome of Clostridium difficile isolates determined using phenotype microarrays.

Authors:  Joy Scaria; Jenn-Wei Chen; Nicodemus Useh; Hongxuan He; Sean P McDonough; Chunhong Mao; Bruno Sobral; Yung-Fu Chang
Journal:  Int J Infect Dis       Date:  2014-08-12       Impact factor: 3.623

6.  Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children.

Authors:  Jonathan D Crews; Lauren R Anderson; D Kim Waller; Michael D Swartz; Hebert L DuPont; Jeffrey R Starke
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 2.129

7.  Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.

Authors:  V Sathyendran; G N McAuliffe; T Swager; J T Freeman; S L Taylor; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

Review 8.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

9.  A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Authors:  Y Chen; K Glass; B Liu; T V Riley; R Korda; M D Kirk
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

10.  Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease.

Authors:  Frederic D Bushman; Maire Conrad; Yue Ren; Chunyu Zhao; Christopher Gu; Christopher Petucci; Min-Soo Kim; Arwa Abbas; Kevin J Downes; Nina Devas; Lisa M Mattei; Jessica Breton; Judith Kelsen; Sarah Marakos; Alissa Galgano; Kelly Kachelries; Jessi Erlichman; Jessica L Hart; Michael Moraskie; Dorothy Kim; Huanjia Zhang; Casey E Hofstaedter; Gary D Wu; James D Lewis; Joseph P Zackular; Hongzhe Li; Kyle Bittinger; Robert Baldassano
Journal:  Cell Host Microbe       Date:  2020-08-20       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.